‘Amniotic stem cells represent a significant hope for the future of stem cell therapy,’ says Professor Giuseppe Simoni, Scientific Director of Biocell Middle and Professor of Individual Genetics at the University of Milan. ‘Biocell Middle has been studying cells from amniotic fluid for years and may be the only business in the world that provides the provider of amniotic liquid stem cell cryopreservation to ladies performing genetic amniocentesis during their being pregnant.’ ‘The stem cells within the liquid surrounding the fetus have become important and beneficial,’ concludes Simoni. ‘Their collection during genetic amniocentesis will not change the typical procedure, presents no risk and storing them possibly safeguards the continuing future of a child.’.. Amniocentesis and non-embryonic stem cells among set of ‘Huge Medical Breakthroughs’ Two key focus areas of Biocell Center, the country’s first amniotic fluid stem cell bank, have been recently mentioned being among the most essential medical discoveries of the last century.Sammons Tumor Middle , Sarah Cannon /Analysis Institute and Virginia Cancer Professionals . These brand-new centers join the 13 existing MMRC Member Organizations to advertise and facilitating collaborative study and accelerating drug advancement in multiple myeloma, an incurable bloodstream cancer. To time, the MMRC offers advanced 27 early-stage scientific trials. MMRC Member Organizations also donate to the MMRC Cells Bank, which houses a crucial mass of highly-annotated bone marrow and peripheral bloodstream samples from multiple myeloma sufferers, and acts as a bridge between laboratory and scientific research. ‘Carrying out a rigorous evaluation, Baylor Sammons, Sarah Cannon, and Virginia Malignancy Specialists were selected, predicated on both their considerable experience in conducting scientific trials and their amazing reach to the individual community’, stated Kathy Giusti, CEO and Founder of the MMRC.